Caisse de Depot et Placement du Quebec (CDPQ)’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $35M | Buy |
637,269
+580,402
| +1,021% | +$31.9M | 0.07% | 247 |
|
2025
Q1 | $4.02M | Buy |
+56,867
| New | +$4.02M | 0.01% | 483 |
|
2024
Q3 | – | Sell |
-2,677
| Closed | -$220K | – | 503 |
|
2024
Q2 | $220K | Sell |
2,677
-36,653
| -93% | -$3.02M | ﹤0.01% | 454 |
|
2024
Q1 | $3.44M | Sell |
39,330
-28,118
| -42% | -$2.46M | 0.01% | 402 |
|
2023
Q4 | $6.5M | Buy |
67,448
+22,735
| +51% | +$2.19M | 0.02% | 327 |
|
2023
Q3 | $3.96M | Sell |
44,713
-12,800
| -22% | -$1.13M | 0.01% | 346 |
|
2023
Q2 | $4.99M | Buy |
57,513
+5,130
| +10% | +$445K | 0.01% | 350 |
|
2023
Q1 | $5.09M | Sell |
52,383
-27,700
| -35% | -$2.69M | 0.01% | 389 |
|
2022
Q4 | $8.29M | Buy |
80,083
+40,300
| +101% | +$4.17M | 0.03% | 346 |
|
2022
Q3 | $3.37M | Buy |
39,783
+15,787
| +66% | +$1.34M | 0.01% | 405 |
|
2022
Q2 | $1.99M | Sell |
23,996
-7,738
| -24% | -$641K | 0.01% | 450 |
|
2022
Q1 | $2.45M | Buy |
31,734
+28,400
| +852% | +$2.19M | 0.01% | 490 |
|
2021
Q4 | $295K | Sell |
3,334
-3,095
| -48% | -$274K | ﹤0.01% | 555 |
|
2021
Q3 | $497K | Buy |
6,429
+1,400
| +28% | +$108K | ﹤0.01% | 501 |
|
2021
Q2 | $420K | Buy |
+5,029
| New | +$420K | ﹤0.01% | 477 |
|
2020
Q4 | – | Sell |
-2,800
| Closed | -$213K | – | 683 |
|
2020
Q3 | $213K | Sell |
2,800
-1,600
| -36% | -$122K | ﹤0.01% | 678 |
|
2020
Q2 | $543K | Sell |
4,400
-950
| -18% | -$117K | ﹤0.01% | 622 |
|
2020
Q1 | $452K | Buy |
5,350
+1,450
| +37% | +$123K | ﹤0.01% | 665 |
|
2019
Q4 | $330K | Sell |
3,900
-6,000
| -61% | -$508K | ﹤0.01% | 674 |
|
2019
Q3 | $667K | Buy |
9,900
+300
| +3% | +$20.2K | ﹤0.01% | 744 |
|
2019
Q2 | $822K | Sell |
9,600
-300
| -3% | -$25.7K | ﹤0.01% | 645 |
|
2019
Q1 | $879K | Sell |
9,900
-2,400
| -20% | -$213K | ﹤0.01% | 628 |
|
2018
Q4 | $1.05M | Sell |
12,300
-300
| -2% | -$25.5K | ﹤0.01% | 595 |
|
2018
Q3 | $1.22M | Buy |
12,600
+9,500
| +306% | +$921K | ﹤0.01% | 592 |
|
2018
Q2 | $292K | Sell |
3,100
-1,000
| -24% | -$94.2K | ﹤0.01% | 753 |
|
2018
Q1 | $332K | Buy |
4,100
+1,300
| +46% | +$105K | ﹤0.01% | 700 |
|
2017
Q4 | $250K | Sell |
2,800
-1,300
| -32% | -$116K | ﹤0.01% | 699 |
|
2017
Q3 | $383K | Buy |
4,100
+200
| +5% | +$18.7K | ﹤0.01% | 694 |
|
2017
Q2 | $353K | Buy |
3,900
+1,100
| +39% | +$99.6K | ﹤0.01% | 693 |
|
2017
Q1 | $246K | Sell |
2,800
-10,200
| -78% | -$896K | ﹤0.01% | 680 |
|
2016
Q4 | $1.08M | Sell |
13,000
-2,600
| -17% | -$215K | ﹤0.01% | 599 |
|
2016
Q3 | $1.44M | Sell |
15,600
-800
| -5% | -$74K | ﹤0.01% | 608 |
|
2016
Q2 | $1.28M | Buy |
16,400
+6,400
| +64% | +$498K | ﹤0.01% | 686 |
|
2016
Q1 | $825K | Buy |
+10,000
| New | +$825K | ﹤0.01% | 718 |
|
2013
Q3 | – | Sell |
-4,800
| Closed | -$268K | – | 777 |
|
2013
Q2 | $268K | Buy |
+4,800
| New | +$268K | ﹤0.01% | 782 |
|